CAS 1184919-23-0

2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(o-tolyl)thiazole-5-carboxamide (Dasatinib Impurity)

CAS : 1184919-23-0

Formule : C₂₂H₂₇N₇O₂S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 453.5605

Ref: IN-DA008W67

Dasatinib Impurity 4

CAS : 1184919-23-0

Formule : C₂₂H₂₇N₇O₂S

Couleur et forme : Pale Yellow Solid

Masse moléculaire : 453.57

Ref: 4Z-D-309

2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(o-tolyl)thiazole-5-carboxamide (Dasatinib Impurity)

CAS : 1184919-23-0

2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(o-tolyl)thiazole-5-carboxamide (Dasatinib Impurity）

Degré de pureté : 98%

Masse moléculaire : 453.56g/mol

Ref: 54-OR1007263

Deschloro Dasatinib

Produit contrôlé

CAS : 1184919-23-0

Formule : C₂₂H₂₇N₇O₂S

Couleur et forme : Brown

Masse moléculaire : 453.56

Ref: TR-D289265

Deschloro Dasatinib-d7

Produit contrôlé

CAS : 1184919-23-0

Formule : C₂₂D₇H₂₀N₇O₂S

Couleur et forme : Neat

Masse moléculaire : 460.604

Ref: TR-D289267

Dasatinib impurity

CAS : 1184919-23-0

Dasatinib is a cancer drug that is used to treat patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It inhibits the activity of tyrosine kinases, in particular Bcr-Abl and Src. Dasatinib is a structural analog of imatinib, which has been shown to be effective against chronic myeloid leukemia by inhibiting the activity of Bcr-Abl. Dasatinib impurity is an unwanted substance found in dasatinib. It can be synthesized from formic acid, chloride and chlorine using a series of industrial processes. The salt form of dasatinib impurity is acidic and synthetic.

Formule : C₂₂H₂₇N₇O₂S

Degré de pureté : Min. 95%

Masse moléculaire : 453.56 g/mol

Ref: 3D-FH167822

Dasatinib Impurity 4

CAS : 1184919-23-0

Formule : C₂₂H₂₇N₇O₂S

Masse moléculaire : 453.56

Ref: ST-EA-CP-D1012